Literature DB >> 8476198

Localization of the alpha 3 beta 1 integrin in some common epithelial tumors of the ovary and in normal equivalents.

A Bartolazzi1, J Kaczmarek, G Nicoló, A M Risso, G Tarone, P Rossino, P Defilippi, P Castellani.   

Abstract

Monoclonal antibodies (mAbs) against cultured human ovary carcinoma cells were produced. We obtained 7 mAbs which reacted diffusely with carcinoma of the ovary but only weakly with vessels and the surface epithelial layer of normal ovary. Biochemical characterization of these mAbs indicated that 3 out of 7 were specific for the alpha 3 chain of the Vla-3 integrin, a receptor for fibronectin, collagen and laminin. Using one of these mAbs, we have studied, by immunohistochemical methods, the distribution of alpha 3 beta 1 integrin in mucinous, serous and endometrioid cystoadenocarcinoma of the ovary and in their normal equivalent: endocervical, tubal and endometrial epithelia. The results show that alpha 3 beta 1 is present in cell-cell contact areas and more abundantly at the junction between epithelial cells and basement membrane in endocervical, tubal epithelia, in epithelium lining the cavity of the uterus and in surface epithelium of the ovary. However, endometrial glands showed only weak and fragmented positivity at the basal pole of the cells. 26 out of 31 ovarian cancers studied, expressed the alpha 3 beta 1 integrin. However, basal localization, typical of normal epithelia, is not prominent or disappears in tumors and is replaced by a more diffuse reaction with variable immunohistochemical staining of the neoplastic cells. Furthermore, a comparative analysis of the expression of alpha 3 beta 1 and its ligands, laminin (LM), fibronectin (FN) and collagen IV (Coll IV), demonstrated that basal polarization of Vla-3 was always correlated with the presence of laminin and Coll IV, intrinsic components of the basement membranes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476198

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  Physiological and pathological roles of alpha3beta1 integrin.

Authors:  Tsutomu Tsuji
Journal:  J Membr Biol       Date:  2004-08-01       Impact factor: 1.843

2.  Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.

Authors:  Nao Suzuki; Atsushi Higashiguchi; Yuko Hasegawa; Hiroshi Matsumoto; Shinji Oie; Kimiko Orikawa; Sachiko Ezawa; Nobuyuki Susumu; Ki-Ichi Miyashita; Daisuke Aoki
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

3.  Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.

Authors:  Nuzhat Ahmed; Clyde Riley; Greg Rice; Michael Quinn
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Expression of alpha V-associated integrin beta subunits in epithelial ovarian cancer and its relation to prognosis in patients treated with platinum-based regimens.

Authors:  Sylvie Maubant; Séverine Cruet-Hennequart; Soizic Dutoit; Yves Denoux; Hubert Crouet; Michel Henry-Amar; Pascal Gauduchon
Journal:  J Mol Histol       Date:  2005-02       Impact factor: 2.611

5.  Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.

Authors:  Gianluigi Giannelli; Emilia Fransvea; Felice Marinosci; Carlo Bergamini; Silvia Colucci; Oronzo Schiraldi; Salvatore Antonaci
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

6.  Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin.

Authors:  A P Skubitz; R C Bast; E A Wayner; P C Letourneau; M S Wilke
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

7.  Extracellular Vesicle Integrins Distinguish Unique Cancers.

Authors:  Stephanie N Hurwitz; David G Meckes
Journal:  Proteomes       Date:  2019-04-11

8.  Endoplasmic reticulum oxidoreductase 1 alpha modulates prostate cancer hallmarks.

Authors:  Julian Cornelius; Ilaria Cavarretta; Edoardo Pozzi; Giovanni Lavorgna; Irene Locatelli; Tiziana Tempio; Francesco Montorsi; Agostino Mattei; Roberto Sitia; Andrea Salonia; Tiziana Anelli
Journal:  Transl Androl Urol       Date:  2021-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.